Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project

Recruiting N/A Interventional Study
ERAS Cardiac Surgery Cardiac Surgery-CABG Digital Health
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
480 (estimated)
Sponsor
University of Sao Paulo General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardiovascular diseases continue to be the leading cause of death worldwide. Among them, coronary artery disease has the greatest impact, being characterized as one of the main causes of death in Brazil over the last decade. One of the well-established treatments is coronary artery bypass grafting, which is the most performed among cardiac surgeries and, in our scenario, is primarily funded by the…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults over 18 years old * Indication for primary isolated CABG (elective or urgent status) * Own a personal cell phone * Have internet access * Knowledgeable in using the device * Full understanding and agreement regarding the informed consent form (ICF) Exclusion Criteria: …
Contacts

Omar A V Mejia, MD, PhD

+551126615014

omar.mejia@incor.usp.br

CONTACT

Gabrielle B Borgomoni, BSc, PhD student

+551126615014

gbborgomoni-biomedicina@hotmail.com

CONTACT